白血病中复制时序改变影响临床相关染色体结构域
该研究通过移植免疫缺陷小鼠正常人类CD34+脐血细胞,获得再生B系群体的复制时序(RT)特征,并与大量不同遗传亚型和结局的BCP-ALL患者白血病细胞RT特征比较。结果识别出BCP-ALL亚型特异性特征,部分类似B细胞分化的特定阶段,部分似乎与复发相关。提示BCP-ALL发生涉及RT改变,反映具生物学意义和潜在临床相关性的白血病特异性表观遗传变化。
要点
- BCP-ALL细胞具有独特、克隆可遗传且稳定的DNA复制时序程序
- BCP-ALL亚型特异性RT特征部分模拟正常B细胞分化阶段
- 部分RT特征似乎与白血病复发相关
核心结论
- BCP-ALL的发生涉及复制时序改变,这些改变反映具生物学意义和潜在临床相关性的白血病特异性表观遗传变化。
研究设计与样本
- 移植免疫缺陷小鼠正常人类CD34+脐血细胞,获得再生B系群体RT特征,并与大量不同遗传亚型和结局的BCP-ALL患者白血病细胞RT特征比较。
主要发现
- 识别出BCP-ALL亚型特异性特征,部分类似B细胞分化的特定阶段。
- 部分RT特征似乎与复发相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human B-cell precursor acute lymphoid leukemias (BCP-ALLs) comprise a group of genetically and clinically distinct disease entities with features of differentiation arrest at known stages of normal B-lineage differentiation. We previously showed that BCP-ALL cells display unique and clonally heritable, stable DNA replication timing (RT) programs (ie, programs describing the variable order of replication and subnuclear 3D architecture of megabase-scale chromosomal units of DNA in different cell types). To determine the extent to which BCP-ALL RT programs mirror or deviate from specific stages of normal human B-cell differentiation, we transplanted immunodeficient mice with quiescent normal human CD34+ cord blood cells and obtained RT signatures of the regenerating B-lineage populations. We then compared these with RT signatures for leukemic cells from a large cohort of BCP-ALL patients with varied genetic subtypes and outcomes. The results identify BCP-ALL subtype-specific features that resemble specific stages of B-cell differentiation and features that seem to be associated with relapse. These results suggest that the genesis of BCP-ALL involves alterations in RT that reflect biologically significant and potentially clinically relevant leukemia-specific epigenetic changes.
引用
- Rivera-Mulia JC, Sasaki T, Trevilla-Garcia C, et al. Replication timing alterations in leukemia affect clinically relevant chromosome domains. Blood Adv. 2019. PMID: 31698451. doi:10.1182/bloodadvances.2019000641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。